Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03274310 · ClinicalTrials.gov registry record · NA
FluSAFE: Flu SMS Alerts to Freeze Exposure
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 1,918
- Enrollment target
NCT03274310 is a NA study that has completed, run by Columbia University. The registered enrollment target is 1,918 participants.
The verdict
NCT03274310, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,918 participants
- Enrollment target
Study Summary
Influenza infection results in an estimated 31 million outpatient visits, 55,000 to 974,200 hospitalizations, and 3,000 to 49,000 deaths. Membership in household in which someone else has influenza is the major risk factor for contracting influenza. The household secondary attack rate (SAR) is as high as 19% based on laboratory-confirmed influenza and 30% based on symptoms. Non-pharmaceutical preventive measures, including education, may play a role in decreasing transmission, but are only effective if started within 36 hours of symptom onset in index cases. Yet, most interventions are delayed because they are not initiated until care is sought. The investigators have demonstrated in one primarily Latino, urban community sample, that text messaging can be used to rapidly identify community members with influenza-like illness (ILI) early in an illness. This early identification would enable implementation of an educational intervention in the optimal time frame to reduce influenza transmission. Providing education within a text message is a proven successful strategy to influence behavior. Text messaging itself is scalable, low-cost, and can be used in low literacy populations. However, using text-message based surveillance to trigger a real-time text-message behavioral educational intervention to decrease household influenza transmission has not been assessed.
Interventions
- BEHAVIORAL Educational text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,918 participants |
| Start Date | 2017-10-06 |
| Est. Completion | 2021-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03274310
The ClinicalTrials.gov registry entry for NCT03274310 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,918 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Educational text messages is the first listed.
NCT03274310 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03274310 about?
NCT03274310 is a clinical study titled "FluSAFE: Flu SMS Alerts to Freeze Exposure". Influenza infection results in an estimated 31 million outpatient visits, 55,000 to 974,200 hospitalizations, and 3,000 to 49,000 deaths. Membership in household in which someone else has influenza is the major risk factor for contracting influenza. The household secondary attack rate (SAR) is as hi...
What is the current status of trial NCT03274310?
This trial is currently completed. It is a NA study. The enrollment target is 1,918 participants. The study started on 2017-10-06. Estimated completion is 2021-05-15.
What interventions are being tested in trial NCT03274310?
The interventions under investigation include: Educational text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT03274310?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.